Skip to content

The usefulness of cardiac MRI for evaluating myocardial fibrosis (modified T1 mapping)

The usefulness of cardiac MRI for evaluating myocardial fibrosis (modified T1 mapping) - Modified T1 mapping for evaluating myocardial fibrosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000013057
Enrollment
50
Registered
2014-02-03
Start date
2013-02-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiomyopathy, diastolic dysfunction, myocardial infarction

Interventions

None listed

Sponsors

Takeshi Adachi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects must be or more than 20 years old at enrollment, and got informed consent.

Exclusion criteria

Exclusion criteria: patients not applicable to contrast MRI are excluded.

Design outcomes

Primary

MeasureTime frame
Conventional methods for diastolic dysfunction, amino acids relating to oxidative stress, and pathology of cardiac biopsy

Countries

Japan

Contacts

Public ContactNobuyuki Masaki

National Defense Medical College Cardiology

nmasaki@ndmc.ac.jp0429-95-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026